NIH-funded research Sbir 2 grant

Non-Addictive Nose Spray Nerve Block for Quick Migraine Relief

Official title: Development of a Non-Addictive Intranasal Nerve Block to Provide Rapid Acute Treatment for Headache Disorders

Funded at Olfax, LLC · NIH-11405684 · Data updated 2026-11-12

A new nasal nerve-blocking treatment being tested to relieve migraine attacks quickly without addictive drugs.

More Headache research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionOlfax, LLC
NIH-funded
Lab location1 site (Asheville, United States)
Project startSeptember 3, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$1,446,740
NIH project number1R44NS149824-01
Project IDNIH-11405684 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and older who experience migraine episodes and are seeking rapid, non-addictive treatment options.

Less likely to help

Individuals without migraine or those whose attacks do not respond to nasal nerve-block approaches may not benefit.

What this research studies

This project aims to develop a rapid, non-addictive nasal nerve-block formulation to treat acute migraine symptoms. It will explore how delivering a targeted nerve block through the nose can stop migraine pain fast, potentially reducing the need for stronger medications. Researchers plan to test the approach in adults with migraine and monitor safety, pain relief, and any side effects. If successful, the method could offer a convenient, early intervention that patients can use at home or in urgent care settings.

Why it matters

Potential benefit: If successful, patients could experience faster relief from migraine attacks with fewer drug side effects and reduced reliance on opioids or other strong medications.

How similar studies have gone: Previous research supports rapid relief methods targeting trigeminovascular pathways, but this nasal-block approach is a newer, potentially more direct strategy for acute migraine.

Where this research is happening

  • Olfax, LLC
    Asheville, United States
    Active

Researchers

  • Principal investigator: Cook, Jason T — Olfax, LLC
  • Study coordinator: Cook, Jason T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.